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Abstract
Background: Although familial clustering of functional dyspepsia (FD) has been reported, the role of genetics in
the susceptibility to FD is still not well understood. Several reports indicate an association between FD and G-
protein b3 (GNB3) subunit gene polymorphism (C825T); however, these studies had small sample sizes and the
findings are inconclusive. In the present study we clarified the association between GNB3 gene polymorphism and
dyspepsia in a large population of Japanese subjects who visited a hospital for annual health check-up.
Methods: Subjects with significant upper gastrointestinal findings were excluded. Subjects with dyspeptic
symptoms were divided into either a postprandial distress syndrome (PDS) group or an epigastric pain syndrome
(EPS) group according to the Rome III criteria. The presence of the GNB3 C825T polymorphism was then evaluated
and logistic regression analysis was used to test all variables.
Results: The GNB3 genotype distribution in subjects without dyspepsia was 191 CC (25.1%), 368 TC (48.4%), and
202 TT (26.5%) and 17 CC (25.0%), 29 TC (42.6%), and 22 TT (32.4%) in subjects with dyspepsia. No significant
correlation was found between the GNB3 825TT genotype and dyspepsia. However, the TT genotype was
significantly associated with subjects with EPS-like symptoms (odds ratio (OR) = 2.00, 95% confidence interval (CI);
1.07-3.76) compared to the CT/CC genotype adjusted for gender and age. No significant correlation was found
between GNB3 polymorphism and PDS-like symptoms (OR = 0.68, 95% CI; 0.31-1.51). With the exclusion of subjects
with both EPS- and PDS-like symptoms, only the TT genotype was significantly associated with EPS-like symptoms
(OR = 2.73, 95% CI; 1.23-5.91).
Conclusion: The homozygous GNB3 825T allele influences the susceptibility to EPS-like dyspepsia.
Background
Functional dyspepsia (FD) is characterized by the pre-
sence of symptoms thought to originate in a gastroduo-
denal lesion in the absence of any organic or systemic
disease that explains the symptoms [1]. The precise
pathophysiology of the functional gastrointestinal disor-
ders is still unknown, but several pathophysiological
mechanisms have been described as possible etiological
factors: visceral hypersensitivity [2,3], impaired proximal
gastric accommodation [4], delayed gastric emptying [5],
dysfunction of the autonomic nervous system [6] and
underlying psychiatric disturbances [7]. Although risk
factors for FD, including age, gender, Helicobacter pylori
(H. pylori) infection, smoking and psychological distur-
bances, have also been reported, the data are not con-
clusive [8,9].
There is increasing evidence that susceptibility to
functional gastrointestinal disorders is influenced by
hereditary factors. G-protein b3( G N B 3 )s u b u n i tg e n e
polymorphism (C825T) is related to alternative splicing
of the GNB3 protein and G-protein activity. As G-pro-
t e i n sp l a yc r u c i a lr o l e sa st h el i g a n d so fG - p r o t e i nc o u -
pling receptor (GPCR), this dysfunction interferes with
intracellular signal transduction, and the 825T allele is
associated with enhanced G-protein activation [10].
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is associated with several diseases including essential
hypertension [10]. Furthermore, individuals with TT and
CT genotypes have a significantly higher sympathetic
nervous system index and lower parasympathetic ner-
vous system index than those with CC [11]. However, it
is not likely that the C825T polymorphism in the GNB3
gene subunit is involved in mood disorder pathogenesis
or depression [12,13]. In FD patients, 825CC, or CC and
TT, genotypes are reported to be associated with dys-
pepsia [14,15]. On the other hand, the 825T allele is
suggested to be related to dyspepsia in reports from
Japan and the Netherlands [16,17].
Because of these conflicting findings among studies,
we thought it necessary to undertake a large-scale gen-
eral population study. In this study, we examined sub-
jects who underwent an annual health check-up and
investigated the relationship between the GNB3 gene
(C835T) and dyspepsia in the Japanese population.
Methods
Subjects
People visiting Healthcare Center of Social Insurance
Shiga Hospital for annual health check-up were asked
to participate in the study. We estimate that 80% of
those who underwent annual health check-up from
December 2007 to April 2008 agreed to participate in
the study. All subjects were Japanese. One thousand
subjects completed an original self-administered ques-
tionnaire that assessed symptoms of dyspepsia, gastroe-
sophageal reflux disease (GERD) and irritable bowel
syndrome (IBS) according to the ROME III criteria.
Dyspeptic symptoms were defined as pain or discom-
fort in the upper abdomen for the last 3 months, with
symptom onset at least 6 months prior to the check-
up. Postprandial distress syndrome (PDS)-like symp-
toms were defined as postprandial fullness and early
satiation, and epigastric pain syndrome (EPS)-like
symptoms were defined as epigastric pain and epigas-
tric burning for more than 6 months with symptoms.
Age, gender, previous upper gastrointestinal study, pre-
vious medication, smoking and alcohol consumption
were also recorded. Subjects who consumed alcohol
more than 3 days a week, regardless of the amount,
were considered to have a drinking habit. Smoking was
defined as smoking any number of cigarettes daily.
One thousand blood samples were taken and 154 sam-
ples were excluded because of abnormal results in
parameters including ALT or WBC. Upon subject
request, imaging was performed by upper gastrointest-
inal barium study (UGI) in 350 subjects (325 controls,
25 FD cases) and esophagogastroduodenoscopy (EGD)
in 136 subjects (118 controls, 18 FD cases), and 17
subjects were excluded due to the detection of definite
and suspected organic diseases, including gastric and
duodenal ulcers and gastric tumors. In total, 171 sub-
jects (155 control and 16 FD) were excluded from the
study based on abnormal findings. Among the 1000
subjects sampled, 318 controls and 25 dyspeptic sub-
jects were uninvestigated by UGI or EGD. This study
w a sa p p r o v e db ye t h i c sc o m m i t t e e so fb o t ht h eH y o g o
College of Medicine and the Social Insurance Shiga
Hospital and written informed consent was obtained
from all participants.
Genotyping
Genomic DNA was isolated from whole blood using
the QIAamp DNA blood minikit (Qiagen, Hilden, Ger-
many). Genotyping of the C825T polymorphism
(rs5443) was performed in a blinded fashion with Taq-
Man SNP Genotyping Assays (C 2184734 10) using an
ABI Prism 7900 Sequence Detection System (Perkin-
Elmer Applied Biosystems, Foster City, CA, USA).
Statistical Analysis
The distribution of age, body mass index (BMI), ALT
or blood pressure (BP) was tested by the Kolmogorov-
Smirnov test. The median and range in each group
were calculated and differences were compared using
the nonparametric Mann-Whitney U-test when neces-
sary. Differences between GNB3 C825T genotypes and
gender, smoking, or drinking were compared by Fish-
er’s exact test. The distribution of alleles at each locus
was assessed using the c
2 statistic of the Hardy-Wein-
berg equilibrium. We compared GNB3 genotypes in
subjects with abdominal symptoms vs. controls without
symptoms, and assessed the association between speci-
fic types of symptoms and GNB3 C825T polymorph-
ism. A logistic regression analysis was performed to
test the influence of several factors in the association
between the GNB3 C825T polymorphism genotype
distribution and dyspepsia. A P < 0.05 was considered
significant.
Power of the Study
In this study, we assessed the potential association of
symptoms of dyspepsia with GNB3 C825T allele status.
In the healthy Japanese population, approximately 20%
are expected to be homozygous for the 825T allele.
Assuming that approximately 5% of subjects have
symptoms of dyspepsia, a 20% increase in the preva-
lence of a genotype would be of clinical relevance.
Thus, setting a =0 . 0 5a n db = 0.80, 826 asymptomatic
controls and 44 subjects with dyspepsia would be suffi-
cient to identify a clinically relevant difference. The
actual number of enrolled subjects (68 FD cases and
761 controls) has a power of 93% to detect the
assumed difference. For the subgroup analyses for EPS
(68 cases), PDS (43 cases), and EPS excluding PDS (28
cases), the power to assumed difference is 79%, 76%,
and 61%, respectively.
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Participant demographics and GNB3 C825T genotype
distribution are summarized in Table 1. Age, BMI, ALT
and BP (systolic and diastolic) did not follow normal
distributions. The median age of the subjects with dys-
pepsia and the non-dyspeptic controls was 43 (range,
23-69) and 45 (range, 19-83) years. No significant bias
was found between the groups for gender, age, smoking
habit, drinking habit, BMI, ALT, systolic BP, or diastolic
BP. The GNB3 genotype distribution in all subjects in
this study was 208 CC (25.1%), 397 CT (47.9%), and 224
TT (27.0%), this distribution being compatible with the
Hardy-Weinberg equilibrium (P = 0.228). The GNB3
genotype distribution in subjects without dyspepsia
(controls) of 191 CC (25.1%), 368 CT (48.4%), and 202
TT (26.5%), and 17 CC (25.0%), 29 CT (42.6%), and 22
TT (32.4%) in subjects with dyspepsia was also compati-
ble with the Hardy-Weinberg equilibrium. The distribu-
tion of the CC/CT/TT genotypes in the healthy controls
was similar to other reports for Japanese populations
[16,18]. The distribution of allele and genotype frequen-
cies did not differ significantly between males and
females.
The association of genotype with the overall FD phe-
notype compared with asymptomatic controls was not
statistically significant (P = 0.546). Forty-three subjects
had predominantly EPS-like symptoms, whereas 40 had
predominantly PDS-like symptoms; 15 subjects simulta-
neously had EPS- and PDS-like symptoms (Table 1). No
association of genotype in subjects with the EPS or PDS
phenotype compared to that in controls was detected (P
> 0.05). The odds ratios of the GNB3 C825T CT and
TT genotypes relative to the CC genotype for the phe-
notypes of FD, EPS, PDS, and EPS excluding PDS, are
shown in Table 2. There were no significant associations
detected for the CC genotype in each of the FD, EPS or
PDS phenotypes. Of the genotypes, only the TT geno-
type was significantly associated with subjects with EPS-
like symptoms (odds ratio (OR) = 2.00, 95% confidence
interval (CI); 1.07-3.76) adjusted for gender and age
(Table 2). However, there was no association of geno-
types and subjects with PDS-like symptoms (OR = 0.68,
95% CI; 0.31-1.51). After excluding subjects with both
EPS- and PDS-like symptoms, the TT genotype was sig-
nificantly associated with EPS-like symptoms compared
to the CT/CC genotype (OR = 2.73, 95% CI; 1.23-5.91)
and compared to the CC genotype (OR = 3.32, 95% CI;
1.07-10.28) (Table 2). Comparison of the TT/CT geno-
type with the CC genotype showed no significant asso-
ciation for each phenotype.
Discussion
This study evaluated GNB3 C825T polymorphism in a
cohort comprising people with dyspepsia and healthy
controls who visited a health care unit for annual health
check-up. We demonstrated an association between
homozygous GNB3 825T and EPS-like dyspepsia. Our
data are consistent with other data from populations
Table 1 Participant demographics and genotype distributions
Controls
(n = 761)
FD, total
(n = 68)
P
2 EPS
(n = 43)
4
P
2 PDS
(n = 40)
4
P
2
Age (years)
1 45 (19-83) 43 (23-69) 0.164 43 (23-69) 0.079 43 (23-64) 0.053
Sex (male%) 42.7 36.8 0.372 39.5 0.752 32.5 0.251
Smoking (%) 27.6 27.9 1.000 34.9 0.299 27.5 1.000
Drinking (%) 30.0 36.8 0.272 37.2 0.314 32.5 0.726
BMI (kg/m
2)
1 22.0
(15.6-37.1)
21.5
(17.4-29.3)
0.400 21.6
(17.4-29.3)
0.801 20.9
(17.4-29.3)
0.084
ALT (IU/L)
1 18 (4-40) 17 (8-38) 0.478 18 (8-38) 0.965 17 (9-32) 0.189
Blood pressure (mmHg)
1
Systolic 118
(78-223)
117
(78-175)
0.735 116
(95-164)
0.994 115
(78-175)
0.282
diastolic 72
(42-126)
72
(48-104)
0.714 72
(49-104)
0.895 68
(48-104)
0.259
GNB3 genotype (%)
CC (wild type) 25.1 25.0 18.6 25.0
CT 48.4 42.6 39.5 42.6
TT 26.5 32.4 0.546 41.9 0.113 32.4 0.546
P for HWE
3 0.368 0.240 0.282 0.240
1Data are shown as median (range).
2P vs. controls by Mann-Whitney U-test (for age, BMI, ALT, and blood pressure) or Fisher’s exact test (for other variables).
3P for deviation from Hardy-Weinberg equilibrium (HWE).
4Fifteen subjects simultaneously had EPS- and PDS-like symptoms.
FD, functional dyspepsia; EPS, epigastric pain syndrome; PDS, postprandial distress syndrome; BMI, body mass index.
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that homozygous GNB3 825T status is associated with
Japanese dyspeptic subjects without H. pylori infection
[16], while van Lelyveld et al. reported that T allele car-
riers of GNB3 C825T polymorphism are associated with
dyspepsia in a population in the Netherlands [17]. How-
ever, conflicting data have also been reported. Homozy-
gous GNB3 825C status has been associated with
unexplained dyspepsia in a German population [14].
Furthermore, meal-unrelated dyspepsia has been asso-
ciated with both the homozygous GNB3 825T and C
genotypes from the US [15]. These contrasting observa-
tions may be explained by differences in genotypic com-
position of populations in different countries, which
comprise different racial groups. In fact, the frequency
of 825TT is higher in Japanese people than in Cauca-
sians. In addition, the definition of FD or sample selec-
tion may also affect the outcome. Moreover, the effect
of type II error can not be excluded in relatively small
sample sizes. In surveys of patients with uninvestigated
dyspepsia, regular smoking has been identified as a risk
factor in US populations [19]; however, smoking or
drinking habits did not differ between the controls and
FD subjects in the present study.
Involvement of the genotype for the generation of
EPS-like symptoms demonstrated in this study may, in
part, explain the previous findings of familial aggrega-
tion of patients with functional gastrointestinal disorders
[20]. Studies have shown clustering of functional gastro-
intestinal disorders within families and studies of twins
suggest that both genetic and environmental factors
influence manifestation [20,21]. Hereditary factors of
functional gastrointestinal disorders may be at least par-
tially explained by the GNB3 polymorphism. If we can
assume that people develop functional gastrointestinal
disorders before they show symptoms, diagnostic testing
may facilitate identifying disease clusters and treatment.
Furthermore, studies suggest that the effects of medica-
tion can be directly or indirectly mediated through G-
protein coupled receptors. Homozygous 825T allele sta-
tus correlates with the greatest response to therapy with
antidepressants [22].
It has been reported that several gene polymorphisms
are involved in the development of IBS. There were only
five subjects with IBS-like symptoms in the present
study, and thus we could not analyze the involvement of
GNB3 polymorphism in IBS and did not consider IBS in
the analysis. De Vries et al. [23] reported that GERD is
associated with the CT genotype of the GNB3 C825T
polymorphism compared with the CC genotype. In the
present study, 62 subjects with predominant symptoms
of GERD were included. However, no association was
found between the GNB3 C825T genotype and GERD
symptoms. Furthermore, the analysis of data in the pre-
sent study was not affected by concomitant GERD
symptoms in some subjects.
Although the data in the present study are from one
institute and from subjects undergoing annual health
check-up, the frequency of the homozygous T genotype
in the control group is consistent with other studies in
Japan, confirming that the sample population is repre-
sentative of the general Japanese population [16,18]. The
majority of people who undergo health check-ups would
have no symptoms but would have some concerns
about their health. In the present, study 537 subjects
(64.8%) did not have any symptoms and had normal
blood examinations. Restricting the controls to those
willing to undergo EGD or UGI tests may introduce
major selection bias and psychosocial factors can influ-
ence the decision to have these tests. Therefore, we did
not select subjects based on these examinations and
included uninvestigated controls and dyspeptic subjects
in the analysis. The relationship between subjects with
ulcers or H. pylori infection and GNB3 polymorphism
Table 2 Risk of dyspepsia according to GNB3 genotypes
FD, total
(n = 68)
EPS
(n = 43)
1
PDS
(n = 40)
1
EPS excluding PDS
(n = 28)
OR (95%CI) P OR (95%CI) P OR (95%CI) P OR (95%CI) P
GNB3 genotype
CC 1 reference 1 reference 1 reference 1 reference
CT 0.85 (0.45-1.59) 0.605 1.03 (0.44-2.45) 0.943 0.70 (0.33-1.45) 0.335 1.31 (0.40-4.23) 0.657
TT 1.18 (0.61-2. 30) 0.618 2.05 (0.87-4.83) 0.102 0.54 (0.22-1.34) 0.185 3.32 (1.07-10.28) 0.037
Dominant model
TT+CT vs. CC 0.97 (0.54-1.72) 0.910 1.39 (0.63-3.06) 0.414 0.64 (0.32-1.28) 0.207 2.03 (0.69-5.94) 0.196
Recessive model
TT vs. CT+CC 1.32 (0.77-2.45) 0.310 2.00 (1.07-3.76) 0.030 0.68 (0.31-1.51) 0.342 2.73 (1.23-5.91) 0.008
1Fifteen subjects simultaneously had EPS- and PDS-like symptoms.
FD, functional dyspepsia; EPS, epigastric pain syndrome; PDS, postprandial distress syndrome;
OR, sex- and age-adjusted odds ratio, vs. 912 controls, by a multiple logistic regression model; CI, confidence interval.
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between dyspepsia and diet, stress, anxiety, or H. pylori
are not conclusive [24]. In the present study, subjects
with ulcers were excluded from the study and all the
analyzed subjects had normal blood screening findings.
Our data showed that the development of EPS-like
symptoms is associated with the homozygous GNB3
825T genotype. Subjects with EPS-like symptoms are
non-consulters, and thus it is reasonable to assume that
these subjects represent specific subgroups of subjects
with less severe functional disturbances. Consequently,
the results may not be representative of all patients with
functional gastrointestinal disorders. Further studies are
needed to evaluate, in detail, the association between
GNB3 polymorphism and symptoms in subjects who
visit primary, secondary or tertiary care centers.
The higher prevalence of the 825TT genotype, which
is related to enhanced signal transduction upon GPCR
activity, may be involved in gastroduodenal motility and
in the development of dyspeptic symptoms. Functional
symptoms might result in part from genetically altered
GPCR, which could in turn explain the multisystem
manifestations commonly observed in these patients.
Tally et al. showed that up to 25% of the population
experienced early satiety, nausea, upper abdominal pain,
or discomfort, which are symptoms of FD, using a vali-
dated questionnaire [25]. We also investigated the asso-
ciation between GNB3 polymorphism and each of eight
different types of dyspeptic symptoms. However, no cor-
relation was found between GNB3 polymorphism and
any of these symptoms (data not shown).
Conclusions
We have demonstrated an association between EPS-like
dyspeptic subjects and the GNB3 825TT genotype in
the Japanese population. Further studies are needed to
elucidate the specific signal transduction pathways
affected by this genetic disorder.
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